Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013

Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020

Published:2021-09-26 Issue: Volume: Page:
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Alsuhibani Abdulrahman^ORCID,Alrasheed Marwan,Gari Musaab,Hincapie Ana L.,Guo Jeff Jianfei

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

https://link.springer.com/content/pdf/10.1007/s11096-021-01330-2.pdf

Reference53 articles.

1. GHO | By category | Overweight / Obesity [Internet]. [cited 2021]. Available from: https://apps.who.int/gho/data/node.main.A896?lang=en.

2. Products - Data Briefs - Number 360 - February 2020 [Internet]. [cited 2020]. Available from: https://www.cdc.gov/nchs/products/databriefs/db360.htm.

3. The State of Obesity 2020: Better Policies for a Healthier America - tfah [Internet]. [cited 2020]. Available from: https://www.tfah.org/report-details/state-of-obesity-2020/.

4. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581–6.

5. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stratified analysis of the association between anti-obesity medications and digestive adverse events: a real-world study based on the FDA adverse event reporting system database;BMC Pharmacology and Toxicology;2024-09-12

2. The Degree of Inulin Polymerization Is Important for Short-Term Amelioration of High-Fat Diet (HFD)-Induced Metabolic Dysfunction and Gut Microbiota Dysbiosis in Rats;Foods;2024-03-28

3. Effectiveness and safety of drugs for obesity;BMJ;2024-03-25

4. Anti-obesity pharmacotherapy in adults with chronic kidney disease;Kidney International;2024-02

5. Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database;International Journal of Clinical Pharmacy;2024-01-24